Moderna CEO Explains How Their Vaccine Has Your Cells Produce a "Key Protein of the RSV Virus"

✞ Wishing You a Very Happy Epiphany Day! ✞

🔥 Nurenburg Trials 2.0: CNBC Host Congratulates Moderna CEO for Developing COVID Vaccine Before the Disease Even Hit America’s Shores

"We started the Phase 1 for the RSV vaccine in Jan 2021. And we are just 24 months after announcing Phase 3 positive data. So think about how we have [reduced that] from 6-8 years."

The CEO of Moderna, Stephane Bancel, appeared on Wednesday’s episode of ‘Squawk Box’ to talk about the company’s recent successes and the forthcoming release of an RSV mRNA vaccine.

During the discussion, CNBC host Rebecca Quick revealed that Bancel told her during a WEF meeting in 2020 that Moderna was already working on a COVID-19 vaccine, even though the disease did not yet exist at the time. Quick was so amazed at how Moderna was so early in developing the vaccine.

“The last time we were here in Davos in the winter was January 2020. And I saw you at that point, and we were at breakfast right over here. I remember, and you came up to me in this small room, and you were talking about how you had actually you were working on a vaccine for COVID. And at that point, COVID-19 didn’t even really exist in our minds,” Quick told Bancel.

Bancel responded, “I think there was no name at that time.”

“It’s amazing how much you’ve accomplished in such a short amount of time,” Quick said.